-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HfXC8xEueWNiG5yyBH4BvX2w1DJ9pvFTNsrlPskt1zprwD0FdNA6xRMZqvL4g6Yg y018IGVP+T37UzvF/tlnfw== 0001011438-08-000125.txt : 20080208 0001011438-08-000125.hdr.sgml : 20080208 20080208171749 ACCESSION NUMBER: 0001011438-08-000125 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080208 DATE AS OF CHANGE: 20080208 GROUP MEMBERS: RICHARD C. PERRY SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: China Medical Technologies, Inc. CENTRAL INDEX KEY: 0001326059 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-81526 FILM NUMBER: 08590228 BUSINESS ADDRESS: STREET 1: NO.24 YONG CHANG NORTH ROAD STREET 2: BEIJING ECONOMIC-TECHNOLOGICAL CITY: DEVELOPMENT AREA, BEIJING STATE: F4 ZIP: 100176 BUSINESS PHONE: (86-10) 6787 1166 MAIL ADDRESS: STREET 1: NO.24 YONG CHANG NORTH ROAD STREET 2: BEIJING ECONOMIC-TECHNOLOGICAL CITY: DEVELOPMENT AREA, BEIJING STATE: F4 ZIP: 100176 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: PERRY CORP CENTRAL INDEX KEY: 0000919085 IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 767 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10153 BUSINESS PHONE: 2125834000 MAIL ADDRESS: STREET 1: 767 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10153 SC 13G/A 1 form_sc13ga-chinamed.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 1)* CHINA MEDICAL TECHNOLOGIES, INC. (Name of Issuer) ORDINARY SHARES, PAR VALUE US$0.10 PER SHARE (Title of Class of Securities) 169483104 (CUSIP Number) DECEMBER 31, 2007 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Continued on following pages Page 1 of 10 Pages Exhibit Index: Page 8 CUSIP NO. 169483104 PAGE 2 OF 10 PAGES 1 Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) PERRY CORP. 2 Check the Appropriate Box If a Member of a Group (See Instructions) a. [ ] b. [ ] 3 SEC Use Only 4 Citizenship or Place of Organization NEW YORK, UNITED STATES 5 Sole Voting Power Number of 33,749,950 Shares Beneficially 6 Shared Voting Power Owned By 0 Each Reporting 7 Sole Dispositive Power Person 33,749,950 With 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned by Each Reporting Person 33,749,950 10 Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11 Percent of Class Represented By Amount in Row (9) 12.34%(1) 12 Type of Reporting Person (See Instructions) IA, CO - -------------------- (1) The percentage set forth above is based upon an aggregate of 273,600,001 ordinary shares, par value US$0.10 per share, of China Medical Technologies, Inc. outstanding as of March 31, 2007. CUSIP NO. 169483104 PAGE 3 OF 10 PAGES 1 Names of Reporting Persons I.R.S. Identification Nos. of above persons (entities only) RICHARD C. PERRY 2 Check the Appropriate Box If a Member of a Group (See Instructions) a. [ ] b. [ ] 3 SEC Use Only 4 Citizenship or Place of Organization UNITED STATES 5 Sole Voting Power Number of 33,749,950 Shares Beneficially 6 Shared Voting Power Owned By 0 Each Reporting 7 Sole Dispositive Power Person 33,749,950 With 8 Shared Dispositive Power 0 9 Aggregate Amount Beneficially Owned by Each Reporting Person 33,749,950 10 Check Box If the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions) [ ] 11 Percent of Class Represented By Amount in Row (9) 12.34%(2) 12 Type of Reporting Person (See Instructions) IN, HC - -------------------- (2) The percentage set forth above is based upon an aggregate of 273,600,001 ordinary shares, par value US$0.10 per share, of China Medical Technologies, Inc. outstanding as of March 31, 2007. CUSIP NO. 169483104 PAGE 4 OF 10 PAGES ITEM 1(A) NAME OF ISSUER: China Medical Technologies, Inc. (the "Issuer"). ITEM 1(B) ADDRESS OF THE ISSUER'S PRINCIPAL EXECUTIVE OFFICES: No. 24 Yong Chang North Road Beijing Economic-Technological Development Area Beijing 100176 People's Republic of China ITEM 2(A) NAME OF PERSON FILING: This statement is filed on behalf of each of the following persons (collectively, the "Reporting Persons"): i) Perry Corp.; and ii) Richard C. Perry, in his capacities as the President and sole stockholder of Perry Corp. ("Mr. Perry"). This statement relates to Shares (as defined herein) held for the accounts of two or more private investment funds for which Perry Corp. acts as general partner and/or managing member of the general partner and/or investment adviser. ITEM 2(B) ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE: The address of the principal business office of each of the Reporting Persons is 767 Fifth Avenue, New York, New York 10153. ITEM 2(C) CITIZENSHIP: 1) Perry Corp. is a New York corporation; and 2) Mr. Perry is a citizen of the United States. ITEM 2(D) TITLE OF CLASS OF SECURITIES: Ordinary Shares, par value US$0.10 per share (the "Shares"). ITEM 2(E) CUSIP NUMBER: 169483104 ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B) OR (C), CHECK WHETHER THE PERSON FILING IS A: i) Perry Corp. is an investment adviser registered under Section 203 of the Investment Advisers Act of 1940. ii) Mr. Perry is a control person of Perry Corp. CUSIP NO. 169483104 PAGE 5 OF 10 PAGES ITEM 4. OWNERSHIP: ITEM 4(A) AMOUNT BENEFICIALLY OWNED: As of the Date of Event, each of the Reporting Persons may be deemed to be the beneficial owner of 33,749,950 Shares. ITEM 4(B) PERCENT OF CLASS: As of March 31, 2007, the number of Shares outstanding was 273,600,001 according to the Issuer's Form 20-F filed on September 28, 2007. As of the Date of Event, each of the Reporting Persons may be deemed to be the beneficial owner of approximately 12.34% of the total number of Shares outstanding held through American Depositary Receipts. ITEM 4(C) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
PERRY CORP. (i) Sole power to vote or direct the vote 33,749,950 (ii) Shared power to vote or to direct the vote 0 (iii) Sole power to dispose or to direct the disposition of 33,749,950 (iv) Shared power to dispose or to direct the disposition of 0 MR. PERRY (i) Sole power to vote or direct the vote 33,749,950 (ii) Shared power to vote or to direct the vote 0 (iii) Sole power to dispose or to direct the disposition of 33,749,950 (iv) Shared power to dispose or to direct the disposition of 0
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS: This Item 5 is not applicable. ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON: The limited partners of (or investors in) each of the private investment funds for which Perry Corp. acts as general partner and/or managing member of the general partner and/or investment adviser have the right to participate in the receipt of dividends from, or proceeds from the sale of, the securities held for the accounts of their respective funds in accordance with their respective limited partnership interest (or investment percentages) in their respective funds. CUSIP NO. 169483104 PAGE 6 OF 10 PAGES ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY: Perry Corp. is the relevant entity for which Mr. Perry may be considered a control person. Perry Corp. is an investment adviser registered under the Investment Advisers Act of 1940. ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP: This Item 8 is not applicable. ITEM 9. NOTICE OF DISSOLUTION OF GROUP: This Item 9 is not applicable. ITEM 10. CERTIFICATION: By signing below each of the Reporting Persons certifies that, to the best of such person's knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the Issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect. CUSIP NO. 169483104 PAGE 7 OF 10 PAGES SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: February 8, 2008 PERRY CORP. Name: /s/ Michael Neus* --------------------------- By: Richard C. Perry Title: President Date: February 8, 2008 RICHARD C. PERRY By: /s/ Michael Neus* --------------------------- *By Michael Neus, attorney-in-fact CUSIP NO. 169483104 PAGE 8 OF 10 PAGES
EXHIBIT INDEX PAGE NO. A. Joint Filing Agreement, dated as of February 8, 2008, by and among the Reporting Persons.......................................................................... 9 B. Power of Attorney, dated June 21, 2005........................................... 10
CUSIP NO. 169483104 PAGE 9 OF 10 PAGES EXHIBIT A JOINT FILING AGREEMENT The undersigned hereby agree that the statement on Schedule 13G with respect to the Ordinary Shares, par value US$0.10 per share, of China Medical Technologies, Inc., dated as of February 8, 2008, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. Date: February 8, 2008 PERRY CORP. Name: /s/ Michael Neus* --------------------------- By: Richard C. Perry Title: President Date: February 8, 2008 RICHARD C. PERRY By: /s/ Michael Neus* --------------------------- *By Michael Neus, attorney-in-fact CUSIP NO. 169483104 PAGE 10 OF 10 PAGES EXHIBIT B POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENT, that I, RICHARD Perry, hereby make, constitute and appoint each of PAUL LEFF and MICHAEL NEUS acting individually, as my agent and attorney-in-fact for the purpose of executing in my name, (a) in my personal capacity or (b) in my capacity as an officer of, shareholder of or in other capacities with Perry Corp. ("Perry") and each of its affiliates or entities advised by me or Perry, all documents, certificates, instruments, statements, filings and agreements ("documents") to be filed with or delivered to any foreign or domestic governmental or regulatory body or required or requested by any other person or entity pursuant to any legal or regulatory requirement relating to the acquisition, ownership, management or disposition of securities, futures contracts or other investments, and any other documents relating or ancillary thereto, including without limitation all documents relating to filings with the Commodity Futures Trading Commission and National Futures Association, the United States Securities and Exchange Commission (the "SEC") pursuant to the Securities Act of 1933 or the Securities Exchange Act of 1934 (the "Act") and the rules and regulations promulgated thereunder, including all documents relating to the beneficial ownership of securities required to be filed with the SEC pursuant to Section 13(d) or Section 16(a) of the Act and any information statements on Form 13F required to be filed with the SEC pursuant to Section 13(f) of the Act. All past acts of these attorneys-in-fact in furtherance of the foregoing are hereby ratified and confirmed. This power of attorney shall be valid from the date hereof until revoked by me. IN WITNESS WHEREOF, I have executed this instrument as of the 21st day of June 2005. /s/ Richard Perry ------------------------------ Richard Perry
-----END PRIVACY-ENHANCED MESSAGE-----